These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 14588063)
1. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR. Bernet L; Zuñiga A; Cano R Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course. Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327 [TBL] [Abstract][Full Text] [Related]
3. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors]. Tang M; Li DQ Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502 [TBL] [Abstract][Full Text] [Related]
4. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541 [TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical and molecular study of gastrointestinal stromal tumours. Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951 [TBL] [Abstract][Full Text] [Related]
6. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
7. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors. Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224 [TBL] [Abstract][Full Text] [Related]
8. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Agaimy A; Wünsch PH; Hofstaedter F; Blaszyk H; Rümmele P; Gaumann A; Dietmaier W; Hartmann A Am J Surg Pathol; 2007 Jan; 31(1):113-20. PubMed ID: 17197927 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Miettinen M; Lasota J Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors]. Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325 [TBL] [Abstract][Full Text] [Related]
11. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Miettinen M; Sobin LH; Sarlomo-Rikala M Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809 [TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
15. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland. Tryggvason G; Hilmarsdottir B; Gunnarsson GH; Jónsson JJ; Jónasson JG; Magnússon MK APMIS; 2010 Sep; 118(9):648-56. PubMed ID: 20718716 [TBL] [Abstract][Full Text] [Related]
18. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y. Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244 [TBL] [Abstract][Full Text] [Related]
19. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439 [TBL] [Abstract][Full Text] [Related]
20. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]